Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20312933 | 0.75 | SMN1; SMN2 (0.46) | SLC6A3CYP2D6SLC6A4LMNAPOLB | |
| SCHEMBL2874877 | 0.74 | TSHR (0.43) | SLC6A3CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL12550455 | 0.71 | SMN1; SMN2 (0.47) | SLC6A3CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL12774635 | 0.70 | SLC6A3 (0.56) | SLC6A3CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL10743810 | 0.70 | LMNA (0.42) | SLC6A3CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3956655 | 0.68 | TSHR (0.46) | SLC6A3CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4055535 | 0.67 | ALDH1A1 (0.49) | SLC6A3CYP3A4CYP2D6LMNATDP1 | |
| SCHEMBL17429837 | 0.67 | SLC6A3 (0.63) | SLC6A3CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL27191 | 0.65 | ACHE (0.47) | SLC6A3CYP1A2CYP2D6TSHRSLC6A4 | |
| SCHEMBL3992907 | 0.65 | SCN1A (0.55) | SLC6A3CYP1A2CYP2D6TSHRSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884135-B2 | via fast disintegrating tablets, mucoadhesive films; pharmacokinetics | NEUROHEALING PHARMACEUTICALS, INC. (US) | 2011-02-08 | — | — | US | disclosed |
| US-20090318559-A1 | MODAFINIL-BASED TREATMENT FOR PREMATURE EJACULATION | NEURO-HEALING PHARMACEUTICALS, INC. | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318559-A1 | MODAFINIL-BASED TREATMENT FOR PREMATURE EJACULATION | KLK3, NASP, TES | SLC6A3 20/4885CYP1A2 792/4885CYP3A4 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.